Anti - Diabetic
FREDSITA-TRIO
Dapagliflozin , Sitagliptin, Metformin HCL (Extended Release) Tablets
In stock Tablets
Product information
- Brand name
- FREDSITA-TRIO
- Composition
- Dapagliflozin , Sitagliptin, Metformin HCL (Extended Release) Tablets
- Dosage form
- Tablets
- Therapeutic segment
- Anti - Diabetic
- Availability
- In stock
About FREDSITA
DAPAGLIFLOZIN PROPANEDIOL MONO HYDRATE EQ. TO DAPAGLIFLOZIN 10 MG SITAGLIPTIN PHOSPHATE MONOHYDRATE IP EQ. TO SITAGLIPTIN 100 MG, METFORMIN HYDROCLORIDE IP (IN EXTENDED RELEASE FORM) : 500MG, YELLOW OXIDE OF IRON & TITANIUM DIOXIDE
For the use of a registered medical practitioner, hospital or laboratory only. Product information on this page is intended for healthcare professionals and trade enquiries, and is not a substitute for the approved prescribing information.
Related
More from the portfolio
Need pack sizes, documentation or export details?
Our team can advise on availability, pack configurations and regulatory documentation across the full portfolio.
